 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012
Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
January 29, 2013 / BioArray News - At Investor Confab, Illumina CFO Discusses Sequestration, Japanese Market, BlueGnome
March 12, 2013 / BioArray News - Illumina Saw 'Strong' Q4 Array Performance, Driven by Growth in HumanCore, Custom Products
January 8, 2013 / BioArray News - Consumer Genetics Sales, GWAS, BlueGnome Drive Illumina Q1 Microarray Revenue Growth
April 23, 2013 / BioArray News - NEJM Papers Support Use of Arrays in Prenatal Dx as Sequencing Gains Ground
December 11, 2012 / BioArray News